메뉴 건너뛰기




Volumn 6, Issue 24, 2015, Pages 20570-20577

Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells

Author keywords

Breast cancer; Cancer stem cells; Drug resistance; Drug target; RSK; YB 1

Indexed keywords

ALPHA6 INTEGRIN; BI D1870; DOXORUBICIN; FLUOROURACIL; GEFITINIB; HERMES ANTIGEN; LJI 308; LUTEOLIN; PACLITAXEL; PROTEIN SERINE THREONINE KINASE INHIBITOR; S6 KINASE; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1; PTERIDINE DERIVATIVE;

EID: 84940210760     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4135     Document Type: Article
Times cited : (35)

References (32)
  • 11
    • 13444270324 scopus 로고    scopus 로고
    • Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation
    • Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM and Lannigan DA. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer research. 2005; 65:1027-1034.
    • (2005) Cancer research , vol.65 , pp. 1027-1034
    • Smith, J.A.1    Poteet-Smith, C.E.2    Xu, Y.3    Errington, T.M.4    Hecht, S.M.5    Lannigan, D.A.6
  • 18
    • 84862517728 scopus 로고    scopus 로고
    • Cancer stem cells: current status and evolving complexities
    • Visvader JE and Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell stem cell. 2012; 10:717-728.
    • (2012) Cell stem cell , vol.10 , pp. 717-728
    • Visvader, J.E.1    Lindeman, G.J.2
  • 19
    • 16844368698 scopus 로고    scopus 로고
    • Tumour stem cells and drug resistance
    • Dean M, Fojo T and Bates S. Tumour stem cells and drug resistance. Nature reviews Cancer. 2005; 5:275-284.
    • (2005) Nature reviews Cancer , vol.5 , pp. 275-284
    • Dean, M.1    Fojo, T.2    Bates, S.3
  • 22
    • 78650206189 scopus 로고    scopus 로고
    • The promise and challenges of targeting RSK for the treatment of cancer
    • Stratford AL and Dunn SE. The promise and challenges of targeting RSK for the treatment of cancer. Expert opinion on therapeutic targets. 2011; 15:1-4.
    • (2011) Expert opinion on therapeutic targets , vol.15 , pp. 1-4
    • Stratford, A.L.1    Dunn, S.E.2
  • 25
    • 80051967505 scopus 로고    scopus 로고
    • Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells
    • Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C and Lander ES. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 2011; 146:633-644.
    • (2011) Cell , vol.146 , pp. 633-644
    • Gupta, P.B.1    Fillmore, C.M.2    Jiang, G.3    Shapira, S.D.4    Tao, K.5    Kuperwasser, C.6    Lander, E.S.7
  • 30
    • 84884588475 scopus 로고    scopus 로고
    • RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
    • Ray-David H, Romeo Y, Lavoie G, Deleris P, Tcherkezian J, Galan JA and Roux PP. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance. Oncogene. 2013; 32:4480-4489.
    • (2013) Oncogene , vol.32 , pp. 4480-4489
    • Ray-David, H.1    Romeo, Y.2    Lavoie, G.3    Deleris, P.4    Tcherkezian, J.5    Galan, J.A.6    Roux, P.P.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.